Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins.

The immunological cross-reactivity of several peptides with specific pattern-property characteristics related to the epitopes of human immunodeficiency virus type 1 (HIV-1) gp160/ 120 envelope proteins has been investigated. Proteins with similar primary structures can be expected to show functional or topographic similarities, such as specific epitopes which may cross-react with antibodies derived from the immunisation of animals with other members of the same protein family. These structure-function characteristics may be revealed as periodicities derived from presentations based on the discrete Fourier transformation of the distributions of various physico-chemical amino acid descriptors, constituting the polypeptide backbone and amino acid side-chains of the protein molecule. Such approaches, for example, have permitted prediction of periodicities corresponding to secondary structural motifs, including amphipathic alpha-helices and beta-sheets, within protein sequences, and have helped to clarify potential binding sites for ligands, substrates or cofactors with interacting macromolecules. Based on this approach, characteristic periodicities have been identified which represent common Fourier transform spectral properties of the envelope (ENV) gp160/120 glycoproteins from a range of HIV-1 isolates. In addition, similar periodicities have been detected as components of the discrete Fourier transform representation of the corresponding amino acid descriptors of the CD4 binding domain of gp120. Accordingly, we have synthesised several peptides having periodic characteristics in their discrete Fourier transform representations similar to these HIV-1 proteins. These nonhomologous synthetic peptides induced cross-reactive antibodies in New Zealand White rabbits. Polyclonal antibodies raised to one of these peptides reacted with HIV-1 ENV gp120-related proteins, as determined by enzyme-linked immunosorbent assay and Western blotting techniques. These findings provide further evidence for a role of immunological cross-reactivity and molecular biomimicry in the development of peptide-based vaccines directed against viral or bacterial pathogens.

[1]  P. Y. Chou,et al.  Empirical predictions of protein conformation. , 1978, Annual review of biochemistry.

[2]  R. Levine,et al.  Evidence showing that the 1105 and 1106 isotypic residues of the fourth component of human complement, C4A, are not involved in amide bond formation. , 1994, Molecular immunology.

[3]  D Eisenberg,et al.  Hydrophobicity and amphiphilicity in protein structure , 1986, Journal of cellular biochemistry.

[4]  T. Steitz,et al.  Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. , 1986, Annual review of biophysics and biophysical chemistry.

[5]  J. Sodroski,et al.  Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding , 1990, Journal of virology.

[6]  L. Arthur,et al.  Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. M. Hendry,et al.  Neutralization of primary HIV‐1 isolates by anti‐envelope monoclonal antibodies , 1995, AIDS.

[8]  G. Nakamura,et al.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.

[9]  D. Montefiori,et al.  Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein , 1994, Journal of virology.

[10]  R A Houghten,et al.  Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. , 1992, Science.

[11]  P Bork,et al.  Recognition of different nucleotide-binding sites in primary structures using a property-pattern approach. , 1990, European journal of biochemistry.

[12]  Milton T. W. Hearn,et al.  Physicochemical Basis of Amino Acid Hydrophobicity Scales: Evaluation of Four New Scales of Amino Acid Hydrophobicity Coefficients Derived from RP-HPLC of Peptides , 1995 .

[13]  C. Cheng‐Mayer,et al.  Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene , 1991, Nature.

[14]  C. Debouck,et al.  Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R A Houghten,et al.  Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins. , 2009, International journal of peptide and protein research.

[16]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[17]  I. Cosic.  Macromolecular bioactivity: is it resonant interaction between macromolecules?-theory and applications , 1994, IEEE Transactions on Biomedical Engineering.

[18]  R. Houghten.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Kuiken,et al.  HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. , 1991, Virology.

[20]  D. Ho,et al.  Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody , 1991, Journal of virology.

[21]  J. Karn,et al.  Periodic features in the amino acid sequence of nematode myosin rod. , 1983, Journal of molecular biology.

[22]  M C Peitsch,et al.  Comparative molecular modelling of the Fas-ligand and other members of the TNF family. , 1995, Molecular immunology.

[23]  R M Stroud,et al.  Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Ho,et al.  Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120 , 1992, Journal of virology.

[25]  A. Burny,et al.  Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope. , 1993, Vaccine.

[26]  C. DeLisi,et al.  Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins. , 1987, Journal of molecular biology.

[27]  M. Kanehisa,et al.  Cluster analysis of amino acid indices for prediction of protein structure and function. , 1988, Protein engineering.

[28]  J. Bajorath,et al.  Comparison of a protein model with its X-ray structure: the ligand binding domain of E-selectin. , 1995, Bioconjugate chemistry.

[29]  A J Langlois,et al.  Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M T Hearn,et al.  Studies on protein-DNA interactions using the resonant recognition model. Application to repressors and transforming proteins. , 1992, European journal of biochemistry.

[31]  D. Eisenberg,et al.  The hydrophobic moment detects periodicity in protein hydrophobicity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Jiang,et al.  Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1). , 1992, Virology.

[33]  J. M. Zimmerman,et al.  The characterization of amino acid sequences in proteins by statistical methods. , 1968, Journal of theoretical biology.

[34]  M. Mutter,et al.  Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design , 1992, Protein science : a publication of the Protein Society.

[35]  S. Brunak,et al.  Protein secondary structure and homology by neural networks The α‐helices in rhodopsin , 1988 .

[36]  M C Peitsch,et al.  The Swiss-3DImage collection and PDB-Browser on the World-Wide Web. , 1995, Trends in biochemical sciences.

[37]  M. Gurney,et al.  Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. , 1988, Science.

[38]  R. Hodges,et al.  New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. , 1986, Biochemistry.

[39]  F. Richards,et al.  Identification of structural motifs from protein coordinate data: Secondary structure and first‐level supersecondary structure * , 1988, Proteins.

[40]  J. Sodroski,et al.  Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody , 1991, Journal of virology.

[41]  L. M. Smith,et al.  Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization. , 1993, Virology.

[42]  M T Hearn,et al.  Resonant recognition model and protein topography. Model studies with myoglobin, hemoglobin and lysozyme. , 1991, European journal of biochemistry.